Taurine modulates gut microbiota and attenuates inflammation in a rotenone-induced mouse model of Parkinson's disease

Key Points

• Taurine significantly reduces inflammation in the gut microbiota of the Parkinson's model, enhancing health.
• Key evidence from the study shows a notable reduction in inflammation markers after taurine treatment.
• Analysis using a rotenone-induced mouse model demonstrates the impact of taurine on gut microbiota diversity.
• This work supports the role of taurine in managing inflammation, indicating new avenues for Parkinson's disease therapy.